Compare Vaxcyte Inc. Common Stock (PCVX) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Tesla, Inc. — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Tesla, Inc. trades at $362.5 (market cap $1.48T). The key difference: Tesla, Inc. is far larger — about 140.8× Vaxcyte Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Tesla, Inc. for 88 Days on average.
| PCVX | TSLA | |
|---|---|---|
Market Cap | $10.51B | $1.48T |
Volume | 2,644,694 | 18,314,332 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $489.88 |
52-Week Low | $40.32 | $298.16 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $9.14B | $1.45T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tesla (TSLA) trades at $367.16, down 2.88% on the day, amid mixed signals. The technical outlook is bullish based on moving averages, but oscillators are neutral. Recent earnings showed a Q2 2026 miss after two prior beats. Revenue declined slightly in 2025 to $94.83B, with net income margin compressing to 4%. The company maintains a strong balance sheet with $36.56B in cash, though valuation ratios like a P/E of 347.44 remain elevated. News highlights focus on autonomous driving approvals in Europe and a potential cheaper EV model.
Tesla's investment case balances high growth expectations in autonomy and energy against near-term execution risks and rich valuations. The consensus price target of $441.36 implies upside, but investors face risks from competitive pressures, volatile earnings, and the stock's sensitivity to sentiment shifts around its AI and robotics initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
